Clinical observation of Conbercept in the treatment of patients with wet age-related macular degeneration
AIM: To observe the clinical characteristics and influence factors of different responses in patients with wet age-related macular degeneration(wARMD)treated with intravitreal conbercept.<p>METHODS: A total of 62 eyes(56 patients)with wet age-related macular degeneration who received intravitr...
Main Authors: | Si Zhang, Qing Li, Hui Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Press of International Journal of Ophthalmology (IJO PRESS)
2020-05-01
|
Series: | Guoji Yanke Zazhi |
Subjects: | |
Online Access: | http://ies.ijo.cn/cn_publish/2020/5/202005009.pdf |
Similar Items
-
Comparison of efficacy of intravitreal injection of Ranibizumab and Conbercept in the treatment of exudative age-related macular degeneration
by: Zhong-Qing Li, et al.
Published: (2022-04-01) -
Effect of conbercept or ranibizumab in the treatment of wet age-related macular degeneration
by: Dawei Zhang, et al.
Published: (2019-01-01) -
Analysis on Conbercept for exudative age-related macular degeneration
by: Kun Li, et al.
Published: (2017-12-01) -
Comparison of efficacy between Ranibizumab and Conbercept for wet age-related macular degeneration
by: Qiang Fan, et al.
Published: (2018-08-01) -
Preliminary study of Conbercept injected intravitreally for the treatment of wet age-related macular degeneration
by: Ying Qin, et al.
Published: (2017-08-01)